UnknownPhase 4

Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.

Egypt250 participantsStarted 2024-06-15

Plain-language summary

In this study the investigators aim to study the effect of supplementation of CoQ10 in decreasing the incidence of contrast induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are 18 years or older. * ST-elevation myocardial infarction (STEMI). * Non ST-elevation myocardial infarction( NSTEMI). * Unstable Angina (UA) Exclusion Criteria: * Renal transplant patients. * Preoperative bleeding . * Intraoperative bleeding or hypotension. * Patients taking any nephrotoxic medications

What they're measuring

Percentage of the Creatinine rise in 1st 48-72 hours in ccu

Timeframe: 48-72 hours

Trial details

NCT IDNCT06429345

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

Contact for this trial

Ramy Mohamed, Resident

01002820102 96ramymohamed22@gmail.com

View on ClinicalTrials.gov More Contrast-induced Nephropathy trials